Annovis Bio Inc

NYSE:ANVS  
9.89
-0.56 (-5.36%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Annovis Bio Inc Stock, NYSE:ANVS

1055 Westlakes Drive, Suite 300, Berwyn, Pennsylvania 19312
United States of America
Phone: +1.610.727.3913
Number of Employees: 5
http://www.annovisbio.com

Description

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aims to treat neurodegenerative diseases such as Alzheimer�s (AD) and Parkinson�s (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.